LYTLE PAUL J 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed May 1, 2012
Insider Transaction Report
Form 4
LYTLE PAUL J
Chief Financial Officer
Transactions
- Other
Common Stock
2012-04-30$0.40/sh+12,498$4,999→ 68,618 total
Footnotes (1)
- [F1]Shares acquired under the Peregrine employee stock purchase plan on April 30, 2012.